Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions
worldwide with a high mortality rate due to a lack of definitive treatment. Despite having a …

In December 2019, a novel coronavirus, SARS-CoV-2, appeared, causing a wide range of
symptoms, mainly respiratory infection. In March 2020, the World Health Organization …

At the end of 2019, a highly contagious infection began its ominous conquest of the world. It
was soon discovered that the disease was caused by a novel coronavirus designated as …

After the COVID-19 outbreak, increasing number of patients worldwide who have survived
COVID-19 continue to battle the symptoms of the illness, long after they have been clinically …

Since the initial identification of the novel coronavirus SARS-CoV-2 in December 2019, the
COVID-19 pandemic has become a leading cause of morbidity and mortality worldwide. As …

Since December 2019, coronavirus disease (COVID‐19) has rapidly swept the world. So far,
more than 30 million people have been infected and nearly one million have died. Although …

Patients with coronavirus disease 2019 (COVID-19) usually suffer from post-acute sequelae
of coronavirus disease 2019 (PASC). Pulmonary fibrosis (PF) has the most significant long …

ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19) is still increasing
worldwide, and as a result, the number of patients with pulmonary fibrosis secondary to …

In 2019, an unprecedented disease named coronavirus disease 2019 (COVID-19) emerged
and spread across the globe. Although the rapid transmission of COVID-19 has resulted in …

Although pulmonary fibrosis can occur in the absence of a clear‐cut inciting agent, and
without a clinically clear initial acute inflammatory phase, it is more commonly associated …